68
In band
Moving averages
SMA 200$11.09+24.80%
Company profile
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$3.62B
P/E ratio17.65
EPS$0.78
Beta1.542
Dividend yield0.58%
52-week high$13.83
52-week low$5.67
Similar stocks in Drug Manufacturers - General
RSI alerts for OGN
An email when OGN closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:06 PM EDT